Literature DB >> 22103835

Tetherin antagonism by primate lentiviral nef proteins.

Daniel Sauter1, Frank Kirchhoff.   

Abstract

The multifunctional Nef protein of primate lentiviruses is commonly considered an early viral factor that down-modulates various receptors from the cell surface and modulates several signaling pathways to facilitate viral immune evasion and to render the cell conducive for viral replication. However, Nef also acts during the late stages of infection, e.g. by increasing the infectivity of progeny virions. Just recently, it has become clear that many primate lentiviruses that have been detected in about 40 different monkey and ape species also use Nef to antagonize tetherin (BST2/CD317), a cellular factor that inhibits virus release by tethering nascent viral particles to the cell surface. Exceptions are some simian immunodeficiency viruses (SIVs) infecting Cercopithecus monkeys that employ their accessory Vpu protein to counteract the restriction by tetherin. Furthermore, pandemic HIV-1 group M strains switched from Nef to Vpu and HIV-2 group A isolates from Nef to Env after zoonotic transmission from chimpanzees and sooty mangabeys, respectively, to antagonize the tetherin restriction in humans. These evolutionary switches were most likely enforced by a deletion in the cytoplasmic domain of the human tetherin orthologue that confers resistance to Nef. Here, we summarize some of our current knowledge about Nef-mediated tetherin antagonism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22103835     DOI: 10.2174/157016211798842044

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  8 in total

1.  Simian-Human immunodeficiency viruses expressing chimeric subtype B/C Vpu proteins demonstrate the importance of the amino terminal and transmembrane domains in the rate of CD4(+) T cell loss in macaques.

Authors:  Autumn Ruiz; Kimberly Schmitt; Nathan Culley; Edward B Stephens
Journal:  Virology       Date:  2012-12-05       Impact factor: 3.616

Review 2.  HIV-1 Nef in macrophage-mediated disease pathogenesis.

Authors:  Susanna L Lamers; Gary B Fogel; Elyse J Singer; Marco Salemi; David J Nolan; Leanne C Huysentruyt; Michael S McGrath
Journal:  Int Rev Immunol       Date:  2012-12       Impact factor: 5.311

3.  HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef.

Authors:  Daniel Sauter; Stéphane Hué; Sarah J Petit; Jean-Christophe Plantier; Greg J Towers; Frank Kirchhoff; Ravindra K Gupta
Journal:  Retrovirology       Date:  2011-12-15       Impact factor: 4.602

Review 4.  The macrophage: a therapeutic target in HIV-1 infection.

Authors:  Amit Kumar; Georges Herbein
Journal:  Mol Cell Ther       Date:  2014-04-02

Review 5.  Inhibiting the Ins and Outs of HIV Replication: Cell-Intrinsic Antiretroviral Restrictions at the Plasma Membrane.

Authors:  Toshana L Foster; Suzanne Pickering; Stuart J D Neil
Journal:  Front Immunol       Date:  2018-01-04       Impact factor: 7.561

Review 6.  Examination of the APOBEC3 Barrier to Cross Species Transmission of Primate Lentiviruses.

Authors:  Amit Gaba; Ben Flath; Linda Chelico
Journal:  Viruses       Date:  2021-06-07       Impact factor: 5.048

7.  The ubiquitin-conjugating system: multiple roles in viral replication and infection.

Authors:  Arianna Calistri; Denis Munegato; Ilaria Carli; Cristina Parolin; Giorgio Palù
Journal:  Cells       Date:  2014-05-06       Impact factor: 6.600

8.  HIV-1 Nef counteracts autophagy restriction by enhancing the association between BECN1 and its inhibitor BCL2 in a PRKN-dependent manner.

Authors:  Sergio Castro-Gonzalez; Yuhang Shi; Marta Colomer-Lluch; Ying Song; Kaitlyn Mowery; Sharilyn Almodovar; Anju Bansal; Frank Kirchhoff; Konstantin Sparrer; Chengyu Liang; Ruth Serra-Moreno
Journal:  Autophagy       Date:  2020-02-25       Impact factor: 16.016

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.